MedTrace Logo

FODMAPs and Refractory GERD

NCT02471989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2026-05-14

No results posted yet for this study

Summary

The aim of this study is to determine the effects of a low Fermentescible Oligosaccharides Disaccharides Monosaccharides and Polyols (FODMAP) diet in patients with documented refractory GERD on proton pump inhibitor (PPI) therapy.

Conditions

  • Gastro-esophageal Reflux Disease (GERD)

Interventions

DIETARY_SUPPLEMENT

Low-FODMAP diet

DIETARY_SUPPLEMENT

GERD diet

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Frank ZERBIB, Prof · University Hospital, Bordeaux

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-05
Primary Completion
2018-11-13
Completion
2018-11-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02471989 on ClinicalTrials.gov